UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of June 2022

 

Commission File No. 001-41010

 

MAINZ BIOMED N.V.

(Translation of registrant’s name into English)

 

Robert Koch Strasse 50
55129 Mainz
Germany

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

 

Form 20-F ☒   Form 40-F  ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)  ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)  ☐

 

 

 

 

 

Other Events

 

On June 6, 2022, Mainz Biomed N.V. will mail to certain shareholders pursuant to Dutch law, documents relating to its annual general meeting of shareholders to be held on June 28, 2022. Copies of certain of these documents are attached as exhibits hereto.

 

Exhibit No.   Exhibit
     
99.1   Announcement of Annual General Meeting
99.2   Notice of Annual General Meeting
99.3   Agenda of the Annual General Meeting
99.4   Voting Proxy
99.5   Form of Remuneration Policy
99.6   Form of 2022 Omnibus Incentive Plan

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: June 3, 2022 By: /s/ William J. Caragol
  Name: William J. Caragol
  Title: Chief Financial Officer

 

 

2
 

Mainz BioMed NV (NASDAQ:MYNZ)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Mainz BioMed NV Charts.
Mainz BioMed NV (NASDAQ:MYNZ)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Mainz BioMed NV Charts.